Samsung 카지노사이트 추천logics and Main Track: long term vision unveiled
Yuhan Pharma introduces key pipeline at ‘APAC & LatAm’ Session
South Korean pharmaceutical and bio companies are gearing up to participate in the '2024 JP Morgan Healthcare Conference' (카지노사이트 추천) in California, USA, from January 8th to the 11th. They aim to engage in partnering discussions for global corporations and technology transfer opportunities.
This year marks the 42nd edition of the 카지노사이트 추천, recognized as the largest event in the pharmaceutical and bio investment industry. Anticipated attendance includes about 600 companies in pharmaceuticals, bio, and healthcare, with over 8,000 corporate and investor attendees.
Industry sources revealed on January 4th that key players such as Samsung 카지노사이트 추천logics, Celltrion, Yuhan Corporation, Hanmi Pharmaceutical, SK 카지노사이트 추천pharmaceuticals, Lotte 카지노사이트 추천pharmaceuticals, GC Cell, and Bridge카지노사이트 추천 Therapeutics will be actively participating. Moreover, several other companies are set to join the concurrent '카지노사이트 추천tech Showcase 2024.'
Samsung 카지노사이트 추천logics and Celltrion are slated to present at the 'Main Track' of the event.Samsung 카지노사이트 추천logics, invited by JP Morgan for the eighth consecutive year, will deliver its presentation at the core of the 카지노사이트 추천, focusing on their 2023 achievements, 2024 outlook, and long-term vision under the theme 'Leap Forward, Beyond the Reach of the Past' on January 9th at the Grand Ballroom.
Celltrionplans to unveil the vision of Integrated Celltrion at this year's 카지노사이트 추천 Main Track. Jin-Seok Seo, co-CEO of Celltrion, is expected to present the business vision and objectives alongside Chairman Jung-Jin Seo.
Yuhan Pharmaceuticals, SK Biopharmaceuticals, Lotte Biologics, Kakao Healthcare, and others will conduct presentations focused on the Asia-Pacific and Latin America (APAC & LatAm) sessions at 카지노사이트 추천.
Yuhan Pharmaceuticalswill feature Yeol-Hong Kim, Head of Research and Development (R&D), as the speaker. Kim will discuss the major pipeline, including the non-small cell lung cancer treatment ‘Leclaza (active ingredient: Lazertinib).'
SK 카지노사이트 추천pharmaceuticalswill introduce their achievements and long-term growth drivers for the epilepsy drug 'Xcopri (known as Cenobamate in the U.S.)' during the session, presented by CEO Dong-Hoon Lee.
Lotte 카지노사이트 추천logics, a Contract Development and Manufacturing Organization (CDMO), will showcase mid-to-long-term strategies, whileKakao Healthcarewill introduce their diabetes management solution through CEO Hee Hwang.
Hanmi Pharmaceutical, known for its proprietary platform technology 'Rapid Discovery' and substantial deals, will promote its major pipeline at this year's event.
GC Cellaims to present its 'Blueprint 2.0' business strategy, focusing on in-house natural killer (NK) and CAR-NK cell therapy pipelines. Additionally, companies like SK 카지노사이트 추천science, GI Innovation, ABL 카지노사이트 추천, Dx&Vx, and Mepsgen are also participating.
Bridge카지노사이트 추천 Therapeutics, participating in this 카지노사이트 추천 after a three-year hiatus, aims to leverage the event to engage with global pharmaceutical and bio companies, exploring opportunities for technology transfer on key R&D initiatives and seeking partnerships for new anticancer combination therapies. Additionally, companies like SK Bioscience, GI Innovation, ABL Bio, Dx&Vx, and Mepsgen are also participating in the 카지노사이트 추천 event.
Korean pharmaceutical and bio companies view the JPMorgan Healthcare Conference (카지노사이트 추천) as pivotal for their business development. A bio venture representative emphasized the event's significance, stating, '카지노사이트 추천 sets the stage for shaping our business direction through diverse discussions with global decision-makers.' They added, 'Major deals often emerge during 카지노사이트 추천, making it a pivotal platform for business development.'